FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Prosthesis, Mitral Valve, Percutaneously Delivered
PMA: P240042
·
Supplement: S002
·
Decision Oct 4, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0
Basic Information
- Device Name
- Prosthesis, Mitral Valve, Percutaneously Delivered
- Trade Name
- Tendyne Transcatheter Mitral Valve System
- PMA Number
- P240042
- Supplement Number
- S002
- Device Class
- FDA Class 3
- Product Code
- NPU
- Generic Name
- Prosthesis, mitral valve, percutaneously delivered
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- October 4, 2025
- Date Received
- September 4, 2025
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Postapproval Study Protocol
- Expedited Review
- N
Advisory Committee Statement
Approval of the protocol for the post-approval study, "Registry-Based Real-World Use Surveillance," submitted to comply with the conditions of approval outlined in the approval order for P240042.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NPU | Prosthesis, Mitral Valve, Percutaneously Delivered | FDA class 3 | Unknown |